Welcome to The Briefing: Register or log in to tailor our content to your needs

The Briefing is all about showing you what you're most interested in. Personalize the content on The Briefing by choosing exactly what you want to see.

Subject Relevance
Sections

UCL INSTITUTE OF BIOMEDICAL ENGINEERING

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

IBM (NYSE: IBM) scientists are collaborating with pathologists at the University Hospital Zurich to test a new prototype tool to accurately diagnose different types of cancer. This work is based on a technology developed by IBM scientists called a microfluidic… Read more →

Cookies on IBME website

Our website uses cookies to provide us with important information about visitors. By continuing to browse the site we'll assume that you are happy to receive all cookies set by IBME.